|
|
||||||||
J Thorac Cardiovasc Surg 1997;113:701-711
© 1997 Mosby, Inc.
GENERAL THORACIC SURGERY |
Received for publication August 12, 1996 revisions requested Sept. 30, 1996; revisions received Oct. 31, 1996; accepted for publication Nov. 5, 1996. Address for reprints: Masayoshi Teramachi, MD, Department of Artificial Organs, Research Center for Biomedical Engineering, Kyoto University, 53 Kawahara-cho, Shogoin, Sakyo-ku, Kyoto 606, Japan.
Abstract
Reconstructions of the intrathoracic trachea in 24 dogs were done with the use of 50 mm long collagen-conjugated tracheal prostheses. Omental wrapping was also done in 14 of the dogs (omentopexy group) to evaluate the efficacy of this option in comparison with results in the other 10 dogs (control group). All 24 dogs had uneventful postoperative courses and were killed at 4 weeks or 3, 6, or 12 months after the operation. Better epithelialization and fewer complications, such as mesh exposure and luminal stenosis, were observed in the omentopexy group than in the control group. Angiography and analysis of regenerated blood vessels revealed that vessel ingrowth had started within 4 weeks and that vessel formation reached its maximal point within 6 to 12 months in the omentopexy group. In contrast, revascularization of the subepithelial region in the control group was poor even after 3 months, and vessel formation continued for as long as 12 months. The differences between the two groups were considered to be mainly a result of the speed of blood vessel ingrowth into the regenerated mucosa. We conclude that our prosthesis can be used safely for intrathoracic tracheal reconstruction and that omental wrapping is a useful supplementary method that reduces the occurrence of complications. (J Thorac Cardiovac Surg 1997;113:691-700)
Reconstruction of the trachea is now widely performed when surgery is done because of tracheal stenoses or cancers. At present, end-to-end anastomosis is considered to be the method of choice for defects up to about 6 cm long in adults.
1-3 For patients with larger defects, several types of prostheses have been tried. However, because of the poor results obtained, they have not yet become standard surgical procedures.
4-7
At present, a great deal of effort is being devoted to experimental tracheal reconstructions with the use of, for example, homograft transplantations, tracheal prostheses, and hybrid types of tracheal conduits, which use staged procedures or tissue engineering.
8 We have been developing a new type of tracheal prosthesis that is a composite of a porous prosthesis and biocompatible collagen, and good results have already been achieved with it for reconstruction of the canine cervical trachea,
9 but not for intrathoracic tracheal reconstruction in which the conditions are more severe. The aim of this study was to confirm the safety of our new prosthesis for intrathoracic tracheal reconstruction. Moreover, we evaluated the efficacy of omental wrapping of the anastomotic sites.
Material and methods
Tracheal prosthesis.
The collagen-conjugated tracheal prosthesis used (50 mm long with an internal diameter of 18 to 20 mm) was made with a method similar to that in our previous study.
9 In brief, the prosthesis comprised a cylinder of fine Marlex mesh (CR Bard, Inc., Billerica, Mass.) reinforced by 10 turns of a continuous spiral of polypropylene string (1 mm in diameter) wrapped around it. The spiral was attached to the external surface of the middle 40 mm of the cylinder by thermal melt-bonding at several points and further fixed with 6-0 Prolene suture (Ethicon, Inc., Somerville, N.J.) (Fig. 1). This mesh cylinder was exposed to a plasma charge to introduce peroxides onto its surface, and porcine dermal atelocollagen (supplied by Nippon Meat Packers Inc., Ibaraki, Japan) was immobilized on its surface by graft polymerization of acrylic acid. Then, to prevent air leakage from the pores of the mesh, the cylinder was coated thickly with collagen, which was finally cross-linked by exposure to ultraviolet irradiation to give it stability in vivo.
|
|
Bronchoscopic examination.
Bronchoscopic examination was done periodically after induction of general anesthesia by an intramuscular injection of ketamine hydrochloride (10 mg/kg) and xylazine hydrochloride (4 mg/kg). The luminal surface was observed with a bronchofiberscope (model BF1T20, Olympus Optical Co., Ltd., Tokyo, Japan) to evaluate the coverage by host tissue and complications such as mesh exposure and luminal stenosis.
Histologic examination.
The animals were killed with an injected overdose of sodium pentobarbital 3, 6, or 12 months after reconstruction, and en bloc resection of the prosthesis with the native trachea was done. The prosthesis was divided longitudinally, and mesh exposure on the luminal surface and luminal stenosis were evaluated macroscopically, after which longitudinal sections of the prosthesis were prepared for examination by light and scanning electron microscopy. The extent of epithelial lining on the luminal surface and the extent of inflammatory cell infiltration were evaluated in hematoxylin and eosinstained preparations by light microscopy. At least three longitudinal sections were prepared and the epithelialization rate was determined with the pathologic findings. Moreover, cilia on the epithelial cells were observed by scanning electron microscope (S-450, Hitachi Ltd., Tokyo, Japan).
Comparison of the numbers of vessels in the regenerated mucosa.
Each light microscopic specimen was divided into three equal parts, proximal, middle, and distal, and the numbers of vessels and capillaries in 10 rectangular areas (0.66 x 0.44 mm2) of each part magnified x200 were counted. The results were expressed as means ± standard deviations. Statistical analysis was done by Student's t test, and differences at p < 0.01 were regarded as significant.
Angiography at death.
Angiography was done at the time the dogs were killed 4 weeks or 3, 6, or 12 months after tracheal prosthetic implantation in dogs in both groups and the ingrowth of new vessels into the regenerated mucosa was evaluated. Two dogs in the omentopexy group were subjected to angiography at each interval after the operation: in one dog contrast medium was injected into the celiac trunk and in the other contrast medium was injected into the right carotid artery. In the latter animal, the thoracic aorta was ligated in advance just proximal to the bifurcation of the celiac trunk to evaluate whether the blood flow through the new vessels in the regenerated mucosa originated from the omental pedicle or the bronchial arteries. One control dog was subjected to angiography at each of the same intervals and contrast medium was injected into the right carotid artery.
Each animal received heparin sodium (2 mg/kg) intravenously before being killed with an overdose injection of pentobarbital. The arteries required for angiography were exposed and cannulated with an extension tube. The blood was washed out by perfusion of 1500 to 2000 ml of physiologic saline solution containing heparin sodium (1 mg/100 ml) at a pressure of 200 mm Hg through the inserted tube. Finally, a warmed mixture of 10% wt/vol gelatin and 20% wt/vol barium salt (500 ml) was injected with a syringe. This contrast medium was prepared by the method described by Inoue and colleagues.
10 Immediately after this injection, ice slush was placed around the prosthesis to solidify the gelatin. The prosthesis with the native trachea was resected en bloc 20 minutes later and the surrounding tissue, including the omentum, was removed from the prosthesis and examined roentgenographically.
Animal care.
Each animal received an intravenous injection of 1 gm ampicillin on the day of the operation and a 250 mg/day dose of ampicillin per os for 8 weeks thereafter. The silicone drainage tube placed in the prosthetic lumen was removed with the use of bronchofiberscopic forceps 4 to 8 weeks after the operation. All of the surgical procedures and killing of the animals were done in accordance with the "Guide for the Care and Use of Laboratory Animals" published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).
Results
All the animals in both groups had uneventful postoperative courses and no symptoms that necessitated killing an animal occurred. One control dog was killed at 4 weeks, two at 3 months, three at 6 months, and four at 12 months after reconstruction. In the omentopexy group, 2 dogs each were killed at 4 weeks and 3 months, four at 6 months, and five at 12 months after reconstruction, and one is still alive 18 months after reconstruction. One dog in the omentopexy group that was killed at 12 months was excluded from evaluation, because the viability of the omental pedicle appeared poor at the time of death. Overall, 13 dogs in the omentopexy group and 10 control dogs were included in the analysis to determine the efficacy of omental wrapping.
Bronchoscopic examination.
Mucosal regeneration was observed in all the dogs in both groups when the silicone tube was removed. Mesh exposure was still evident at 6 months in five of the control dogs, and the regenerated mucosa was reddish even at this time. In contrast, in the omentopexy group mesh exposure was observed in only four dogs after 3 months, and within 6 months all but two had no mesh exposure and lustrous mucosa similar to that of the normal trachea (Fig. 3).
|
|
Mesh exposure to the tracheal lumen was observed in all the control dogs and in two dogs of the omentopexy group 3 months after reconstruction. However, after 6 and 12 months, partial mesh exposure was observed in two of the eight dogs in the omentopexy group, compared with five of the seven control dogs
(Table I). The areas of mesh exposure were larger in the control group than in the omentopexy group (Fig. 5).
|
|
Histologic examination.
The dogs killed at 4 weeks were excluded from the histologic study because tissue regeneration on the prosthesis was too poor for preparation of sections for light microscopy. Therefore tissue from 10 and 9 dogs in the omentopexy and control groups, respectively, was evaluated histologically.
All the dogs in both groups had regenerated mucosa with capillary ingrowth (Fig. 6). Although the extent of epithelial lining of the regenerated mucosa on the prosthesis varied, 9 of 10 dogs in the omentopexy group had an epithelial lining covering more than 50% of the length of the prosthesis. In contrast, after 3 and 6 months the control dogs had poor epithelial lining and after 12 months the extent of the epithelial lining was similar to that in the omentopexy group after 6 months. In each animal, ciliated columnar epithelium was observed near the anastomoses, the proportion of nonciliated cuboidal epithelium increased with distance from the anastomoses, and squamous epithelium was observed in the center of the prosthesis (Fig. 7).
|
|
|
|
|
|
We have been developing porous types of tracheal prostheses and have already reported that our 3 cm long prosthesis has a high biocompatibility and can be used safely for cervical tracheal reconstruction.
9 However, with regard to the cervical trachea, even if an end-to-end anastomosis is impossible alternative procedures such as a tracheostomy followed by secondary reconstruction with a skin flap are possible. In contrast, in patients with intrathoracic tracheal defects, such procedures are difficult or impossible, and consequently there are more indications for use of a tracheal prosthesis in the mediastinum than in the neck. With regard to prosthesis length, Jacobs
11 referred to the fact that a relatively short (2 to 4 rings) circumferential tracheal replacement could be accomplished successfully even in the long term and maintained that a tracheal prosthesis should be successfully applicable for much larger defects without the need for periodic endoscopy to maintain the airway. We also considered that a 3 cm long prosthesis might be too short in certain cases, and therefore we designed a 5 cm long prosthesis and used it to reconstruct the canine cervical trachea. However, several complications such as mesh exposure and luminal stenosis occurred.
12
In general, central stenosis has been one of the most frequent complications associated with porous types of tracheal prostheses. This is considered to be caused by a thick granuloma that grows in the center of the prosthesis, possibly as a result of a lack of, or delay in, formation of an epithelial lining. Therefore we believe that this can be prevented if reepithelialization of the luminal surface is completed much more quickly. Rapid tissue invasion into the pores of the mesh and rapid maturation of the subepithelial mucosa are necessary to promote epithelial lining, and there are two possible methods for fulfilling these conditions: (1) enhancement of the tissue affinity of the prosthesis itself and (2) facilitation of host cell invasion into the prosthesis. We therefore constructed a new tracheal prosthesis made of Marlex mesh and collagen sponge. The latter component was used in an attempt to improve the tissue affinity of the prosthesis. In experiments with the canine cervical trachea, this prosthesis overcame the problem of central stenosis, but mesh exposure still occurred.
13
We speculate that the mesh may become exposed in places where the implanted collagen is absorbed before the host tissue has fully invaded the pores of the mesh. If this is the case, then it should be possible to avoid mesh exposure by improving the stability of the collagen. To do this, we used ultraviolet irradiation in our previous studies. However, ultraviolet irradiation alone cannot produce stronger cross-linking to collagen molecules than was achieved for this prosthesis. Chemical agents such as glutaraldehyde, which can produce stronger cross-linking than ultraviolet irradiation, do not seem suitable for tracheal prostheses because of their toxicity.
14 Therefore in this study we had to abandon efforts to induce stronger cross-linking to collagen molecules and instead opted to facilitate tissue invasion into the mesh pores by omental wrapping. This approach has often been used for treatment of avascular areas, such as bronchial fistulas in respiratory operations, and it has been reported to be effective for facilitating neovascularization in tracheal autografts.
15
We would like to emphasize that our prosthesis could be used safely for intrathoracic tracheal reconstruction. For intrathoracic tracheal replacement, unlike that in the neck, it is necessary to overcome more difficult conditions such as poor vascularity and negative pressure. The majority of tracheal prostheses used previously in a clinical setting were the nonporous type, probably because they overcame the problem of air leakage. However, this type of prosthesis could not solve the problem of anastomotic dehiscence and prosthesis displacement.
4,5,7 Our tracheal prosthesis is porous, but the collagen-layer coating is thick enough to prevent air leakage. Deslauriers and associates
6 reported that their tracheal prosthesis made of hard Marlex mesh caused massive fatal bleeding because of erosion of the innominate artery. In the light of this previous experience, therefore, our prosthesis was made of soft Marlex mesh reinforced with a spiral of polypropylene string, which was able to keep the tracheal lumen open against the surrounding pressure. This prosthesis has a certain degree of flexibility, which enables it to move with the neighboring trachea during respiration and as the animals move around. Therefore complications at the sites of anastomosis and erosion of the surrounding organs did not occur even during long-term follow-up for 18 months.
The results of reconstruction in the omentopexy group were apparently better than those in the control group. Mesh exposure and luminal stenosis occurred in only two dogs of the omentopexy group and, moreover, these complications were milder in degree than those in the control group. In contrast, in the control group either mesh exposure or luminal stenosis occurred in all the dogs, and the results were worse than those for cervical tracheal reconstruction.
12 Therefore in conjunction with omental wrapping our prosthesis facilitated good and stable healing of the reconstructed tracheal region. Because these small areas of mesh exposure and mild stenosis did not cause any significant problems, we believe that our prosthesis could be used safely in a clinical setting with omentopexy.
In this study, we evaluated vessel ingrowth into the regenerated mucosa by counting the vessels in prepared sections and also by selective angiography at the time the dogs were killed. Omental wrapping has been used in an attempt to improve graft viability after tracheal allotransplantation for repair of circumferential defects and vessel ingrowth into the graft was reported to start within 1 week of omental wrapping.
15,16 Nelson and colleagues
17 reported that stable healing of tracheal prostheses was accomplished when a subepithelial network of vessels was well advanced by 6 to 8 weeks after reconstruction with omental wrapping. In our study, however, such rapid vessel ingrowth was not observed. In the omentopexy group, a vessel network was first observed after 3 months, and some vertical vessels extending from the outside of the prosthesis to the subepithelial regions were present after 6 months. In the control group, the subepithelial network of vessels was poor even after 12 months.
Although the numbers of vessels increased between 3 and 6 months after the operation and decreased thereafter in the omentopexy group, the numbers of vessels increased from 3 to 12 months in the control group. This suggests that active mucosal proliferation was complete within 6 to 12 months in the omentopexy group, but continued for at least 12 months in the control group.
The extent of the epithelial lining on the prosthesis was greater in the omentopexy group than in the control group. Good (>50%) epithelial lining was observed even after 3 months in the omentopexy group, whereas in the control group this was not evident until after 12 months. These results corresponded to the changes in vessel numbers and progression of luminal stenosis observed bronchoscopically, as we have described. Accordingly, these results led us to speculate that rapid vessel ingrowth as a result of omental wrapping facilitated rapid epithelial migration from the anastomoses, the epithelial lining inhibited excessive proliferation of the regenerated mucosa, and finally the numbers of vessels, which were initially necessary to provide a good supply of blood for tissue proliferation, declined.
Neville, Bolanowski, and Soltanzadeh
18 stated that the ideal tracheal prosthesis should possess six characteristics: it should (1) be airtight, (2) be of adequate consistency, (3) have good acceptance by the host, (4) cause a minimal inflammatory reaction but still be incorporated by the surrounding tissue, (5) be impervious to fibroblastic and bacterial invasion of the lumen, and (6) permit ingrowth of respiratory epithelium along the lumen. Most tracheal prostheses investigated so far have not been able to fulfill the sixth requirement. Recently, a new trial that used a tissue engineering method to induce an epithelial lining on the prosthesis before implantation was reported,
19 but the tissue culture procedures involved appeared too complicated for clinical use. Almost complete epithelialization of our prosthesis, even with the 5 cm long version, was achieved without either staged or complex procedures, and the prosthesis possessed all the ideal characteristics outlined by Neville, Bolanowski, and Soltanzadeh.
18
We conclude that our 5 cm long prosthesis can be used safely for intrathoracic tracheal reconstruction and that omental wrapping of the prosthesis reduces the incidence of associated complications. We found that successful reconstruction was a result of rapid vessel ingrowth into the regenerated mucosa. This prosthesis appears promising for the repair of tracheal defects in human beings.
Footnotes
From the Departments of Artificial Organsa and Biomaterials,b Research Center for Biomedical Engineering, Kyoto University, Kyoto, Japan. ![]()
References
This article has been cited by other articles:
![]() |
T. Sato, H. Tao, M. Araki, H. Ueda, K. Omori, and T. Nakamura Replacement of the left main bronchus with a tissue-engineered prosthesis in a canine model. Ann. Thorac. Surg., August 1, 2008; 86(2): 422 - 428. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jaquet, R. Pilloud, F. J. W. Lang, and P. Monnier Prefabrication of Composite Grafts for Long-Segment Tracheal Reconstruction Arch Otolaryngol Head Neck Surg, October 1, 2004; 130(10): 1185 - 1190. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsukada and H. Osada Experimental study of a new tracheal prosthesis: Pored Dacron tube J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 877 - 884. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Dodge-Khatami, H. W. Niessen, L. H Koole, M. G Klein, T. M van Gulik, and B. A. de Mol Tracheal Replacement in Rabbits with a New Composite Silicone-Metallic Prosthesis Asian Cardiovasc Thorac Ann, September 1, 2003; 11(3): 245 - 249. [Abstract] [Full Text] |
||||
![]() |
H. C. Grillo Tracheal replacement: a critical review Ann. Thorac. Surg., June 1, 2002; 73(6): 1995 - 2004. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Martinod, R. Zegdi, G. Zakine, B. Aupecle, P. Fornes, A. D'Audiffret, J.-C. Chachques, J. Azorin, and A. Carpentier A novel approach to tracheal replacement: The use of an aortic graft J. Thorac. Cardiovasc. Surg., July 1, 2001; 122(1): 197 - 198. [Full Text] [PDF] |
||||
![]() |
T. Sekine, T. Nakamura, K. Matsumoto, Y. Liu, H. Ueda, N. Tamura, and Y. Shimizu CARINAL RECONSTRUCTION WITH A Y-SHAPED COLLAGEN-CONJUGATED PROSTHESIS J. Thorac. Cardiovasc. Surg., June 1, 2000; 119(6): 1162 - 1168. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |